Introduction
Psoriasis is a chronic inflammatory disease that primarily affects the skin, but can also involve the nails [1] . It is more common in Caucasian populations in men as well as women [2] . In Mexicans, it represents 2% of dermatological outpatients [3] . Etiology is multifactorial, including a hereditary component, which is associated with both class I and class II human leukocyte antigen (HLA), and it also influences clinical features, course and severity of the disease [1] [2] [3] .
The early onset of psoriasis is associated with HLACw6 and HLA-B * 57, whereas patients with psoriatic arthritis show a high frequency of HLA-B * 27 (30-60%) [4, 5] . On the other hand, the HLA-DR * 07 has been found in 38.8% of patients with psoriatic arthritis and in 41.5% of
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The lifetime incidence of nail involvement in psoriatic patients is up to 80% [7, [8] [9] [10] [11] [12] [13] . The main changes are pitting, oil drop discoloration, red spotted lunula, splinter hemorrhages, subungual hyperkeratosis and onycholysis [7, 14] . Onychomycosis is the main differential diagnosis and may coexist in up to 30% of these patients [15, 16] . It is believed that the structural alterations caused by the inflammation at the nail matrix may facilitate fungal infection [17, 18] .
Recent studies have shown an autosomal dominant inheritance pattern in onychomycosis [19, 20] . Asz-Sigall et al. [21] demonstrated that HLA-DR * 06 was associated with resistance to nail infection with T. rubrum in Mexican Mestizos.
García-Romero et al. [22] conducted an analysis of the genetic polymorphism of the HLA-B and HLA-DR loci in Mexican patients with dermatophyte onychomycosis and first-degree relatives and found susceptibility genes, namely the HLA-DR * 08 allele.
However, we are not aware of studies of HLA in patients with nail psoriasis and onychomycosis. The aim of this case-control study is to determine whether there is a genetic susceptibility marker for onychomycosis in these patients.
Methods

Cases and Controls
Both cases and controls were prospectively selected at the Department of Dermatology at 'Dr. Manuel Gea González' General Hospital in Mexico City. All cases and controls were Mexican Mestizos, as well as their parents and grandparents.
Cases of suspected onychomycosis in nail psoriasis had a mean age of 45 years (between 37 and 72 years old). They were examined by experienced dermatologists and mycologists. After obtaining ethical approval and informed consent, the patients underwent mycological study (KOH direct mycroscopy and culture in Sabouraud dextrose agar and BBL Mycosel agar, Becton Dickinson and Company, Sparks, Md., USA). The control group were patients with nail psoriasis without onychomycosis confirmed by mycological study. Blood samples were taken from all cases and controls for HLA-DR genotyping.
Total genomic deoxyribonucleic acid (DNA) was extracted from peripheral blood mononuclear cells by using the salting out technique, and purification by the phenol chloroform method.
Identification of Polymorphisms for the HLA-DR Locus
This was accomplished by using the sequence-specific primers method, after amplification of HLA-DR beta 1 chain, using the polymerase chain reaction technique. Gene frequencies were determined in cases and compared to those of controls, significant differences were tested by nonparametric statistics that included the χ 2 analysis and Fisher's exact test by using the StatCalc within the EPIINFO program.
Results
Twenty-five patients and twenty controls with a mean age of 50 years (range 37-72 years) were recruited. The proportion of men to women was 56-44%, in cases as well as controls; 88% had plaque psoriasis ( table 1 ). Table 2 displays the gene frequencies of HLA-DR alleles in each study group. It is readily seen that the HLA-DR * 08 allele is increased in the group of patients (48%) as compared to only 15% in controls, which was statistically significant [p < 0.033, odds ratio (OR) = 3.8, 95% confidence interval (CI): 0. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Likewise, the HLA-DR * 01 allele was found in 9 cases (36%) and only 1 control (5%) (p < 0.023, OR = 8.5, 95% CI: 1-188).
Discussion
These results show the association of the HLA-DR * 08 with the genetic susceptibility to develop onychomycosis in nail psoriatic patients. Interestingly, there is also the possible association of the HLA-DR * 01 in the genetic predisposition to develop onychomycosis; nevertheless, the small sample size of this study suggest further confirmation in a larger cohort of patients and repeating the study design in distinct genetic population.
These results confirm the role of HLA-DR * 08 locus in the pathogenesis of the onychomycosis study by García- Romero et al. [22] ; it should be noted that this study only analyzed patients with onychomycosis and their families, whereas the present study analyzed patients with nail psoriasis and onychomycosis compared with patients with nail psoriasis without onychomycosis. The mechanism by which the HLA-DR * 08 or HLA-DR * 01 confer susceptibility for onychomycosis is multifactorial; nonetheless, the genetic factor is seems to be primarily relevant, probably contributing with other gene and environmental factors in the development of onychomycosis in nail psoriasis.
According to these observations, we conclude that the HLA-DR locus has a role in the pathogenesis of nail psoriasis with onychomycosis and suggest that it might be useful to include the immunogenic profile along with mycological study in order to determine the susceptibility to develop onychomycosis in nail psoriasis.
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